4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-019345
Chief Executive Officer bought 1,530 shares at $6.49 ($9,930)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-14 | Purchase : show line 1 in the form | +1,530 | $6.49 | $9,930 | 63,190 | D |
| Open-market purchases · 1,530 sh · avg $6.49 · $9,930 | ||||||
Loading xslF345X03/doc4.xml…